Cytokine release syndrome after treatment with immune checkpoint inhibitors: an observational cohort study of 2672 patients from Karolinska University Hospital in Sweden by Osama Hamida, Frans Karlsson, Andreas Lundqvist, Marco Gerling, Lisa L. Liu

Subjects: Get full text

Toxic epidermal necrolysis induced by nivolumab therapy for unresectable intraperitoneal cancer by Hiroyoshi Nozaki, Jiro Uehara, Naoki Kato, Masaru Honma, Akemi Ishida-Yamamoto

Subjects: “…checkpoint inhibitors…”
Get full text

A bibliometric study on the impact of gut microbiota on the efficacy of immune checkpoint inhibitors in cancer patients: analysis of the top 100 cited articles by Ziqi Zhao, Kun Xu, Boqian Hu, Yizhuo Jiang, Xisheng Xu, Yuliang Liu

Subjects: Get full text

Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective co... by Zhouwei Zhan, Bijuan Chen, Shaohua Xu, Ruyu Lin, Haiting Chen, Xiaohuan Ma, Xuanping Lin, Wanting Huang, Changhua Zhuo, Yu Chen, Zengqing Guo

Subjects: Get full text

Discontinuation of pembrolizumab for advanced urothelial carcinoma without disease progression: Nationwide cohort study by Katsuhiro Ito, Yuki Kita, Akira Yokomizo, Jun Miki, Yuko Yoshio, Hiroaki Matsumoto, Takehiko Segawa, Takashi Karashima, Naotaka Nishiyama, Kazuto Imai, Shigetaka Suekane, Seiji Nagasawa, Shin Higashi, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi

Subjects: Get full text

Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis by Zhihong Zhao, Jian Ruan, Minjie Fang, Jingwen Liu, Guixiang Liao

Subjects: Get full text

Diabetic Ketoacidosis as a Debut and Immune-Mediated Complication Caused by Pembrolizumab: Case Report by Julian Andrés Pacichana, Luis Miguel Osorio, Katherine Restrepo, Andres Felipe García, Giovanna Rivas, Yamil Liscano

Subjects: Get full text

Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation–Positive NSCLC: An Open-Label Phase 2 Trial (ILLUMINATE) by Chee Khoon Lee, PhD, Bin-Chi Liao, MD, Shalini Subramaniam, MMed (Clin Epi), Chao-Hua Chiu, MD, Antony J. Mersiades, MMed (Clin Epi), Chao-Chi Ho, MD, PhD, Chris Brown, MBiostats, Chun-Liang Lai, MD, PhD, Brett G.M. Hughes, M.B.B.S. (Hons), Tsung-Ying Yang, MD, PhD, Ken O’Byrne, MD, Yung-Hung Luo, MD, PhD, Sonia Yip, PhD, Ching-Liang Ho, MD, Victoria Bray, PhD, Wu-Chou Su, MD, PhD, Melissa Moore, PhD, Wei-Lien Feng, MS, Ya-Ying Bai, MS, Kate Ford, MHSc, Michelle M. Cummins, PhD, Martin R. Stockler, MSc (Clin Epi), Benjamin J. Solomon, PhD, Thomas John, PhD, James Chih-Hsin Yang, MD, PhD

Subjects: Get full text

Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study by Charlie Yue Wang, Mark Shackleton, Sonia Mailer, Grant A. McArthur, Sophia Zoungas, Rory Wolfe, Victoria J. Mar

Subjects: Get full text

Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration by Zhijie Liu, Yiming Fan, Jun Guo, Ning Bian, Dongdong Chen

Subjects: “…Immune checkpoint inhibitors…”
Get full text

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors by Cassie Pan, Kevin Ng, Jenna Voutsinas, Brittany Barber, Zain H. Rizvi, Emily Marchiano, Rocco M. Ferrandino, Neal Futran, George E. Laramore, Jay J. Liao, Upendra Parvathaneni, Neil Panjwani, Renato G. Martins, Cristina P. Rodriguez, Qian “Vicky” Wu

Subjects: Get full text

Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients by Alain Gelibter, Lucrezia Tuosto, Angela Asquino, Marco Siringo, Arianna Sabatini, Ilaria Grazia Zizzari, Angelica Pace, Fabio Scirocchi, Fabio Scirocchi, Flavio Valentino, Serena Bianchini, Salvatore Caponnetto, Donatella Paoli, Filippo Bellati, Daniele Santini, Marianna Nuti, Aurelia Rughetti, Chiara Napoletano

Subjects: Get full text

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs) by A Daban, C Gonnin, L Phan, A Saldmann, C Granier, A Lillo-Lelouet, C Le Beller, J Pouchot, l Weiss, E Tartour, E Fabre, J Medioni, S Oudard, YA Vano, MA Dragon-Durey, A. Simonaggio

Subjects: “…Immune checkpoint inhibitors…”
Get full text

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis by Amjad Zafar, Asma Abdul Rashid, Abdul Moeed, Muhammad Junaid Tahir, Ahmad Jamal Khan, Oadi N. Shrateh, Ali Ahmed

Subjects: Get full text

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy by Jiayuan Le, Yuming Sun, Guangtong Deng, Yating Dian, Yanli Xie, Furong Zeng

Subjects: “…Immune checkpoint inhibitors…”
Get full text

Examining the evidence for immune checkpoint therapy in high-grade serous ovarian cancer by A.E. Connor, P.M. Lyons, A.M. Kilgallon, J.C. Simpson, A.S. Perry, J. Lysaght

Subjects: Get full text

Hyperdifferentiated murine melanoma cells promote adaptive anti-tumor immunity but activate the immune checkpoint system by Yukie Ando, Yutaka Horiuchi, Sara Hatazawa, Momo Mataki, Akihiro Nakamura, Takashi Murakami

Subjects: Get full text

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer by Tadahiro Kuribayashi, Rie Kinoshita, Kiichiro Ninomiya, Go Makimoto, Toshio Kubo, Kammei Rai, Eiki Ichihara, Katsuyuki Hotta, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura, Shinichi Toyooka, Masakiyo Sakaguchi, Kadoaki Ohashi

Subjects: Get full text

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Qianyu Wang, Li Hu, Li Hu, Li Hu, Xiaoxian Sima, Xiaoxian Sima, Xiaoxian Sima, Juncheng Wang, Juncheng Wang, Juncheng Wang, Dandan Hu, Dandan Hu, Dandan Hu, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yizhen Fu, Yizhen Fu, Yizhen Fu

Subjects: Get full text

CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC by Antoine Desilets, MD, MSc, Gabryella Pinheiro, PhD, Wiam Belkaid, PhD, Olivier Salko, MD, Julie Malo, Eleyine Zarour, MD, Adeline Jouquan, MSc, Anne-Julie Thibaudeau, MSc, Marc-Antoine Nolin, MSc, John Stagg, PhD, Marie Florescu, MD, Mustapha Tehfe, MD, Normand Blais, MD, MSc, Samer Tabchi, MD, Jean Chalaoui, MD, Philippe Stephenson, MD, Arielle Elkrief, MD, Vincent Quoc-Huy Trinh, MD, MSc, Bertrand Routy, MD, PhD, Moishe Liberman, MD, PhD

Subjects: Get full text